PharVision Advisers’s Arm ARM Stock Holding History

PharVision Advisers’s Portfolio ARM Stock Details ARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,261	Closed	-$247K	–	134
2025 Q4	$247K	Buy	+2,261	New	+$329K	0.13%	398

Other funds holding ARM

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

PharVision Advisers's ARM Position: Q1 2026 in Review

PharVision Advisers sold out of Arm (ARM) in Q1 2026, closing a stake of 2,261 shares — an estimated $247K sold.

PharVision Advisers first reported a position in ARM in Q4 2025 and held it in 1 quarter. The position peaked at $247K in Q4 2025. 742 funds tracked by Wall St. Rank hold ARM as of Q1 2026.

PharVision Advisers reported no remaining Arm position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,261 Arm shares in Q1 2026, an estimated $247K.
PharVision Advisers first reported a position in Arm in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Arm position peaked at $247K in Q4 2025.
742 funds tracked by Wall St. Rank held Arm as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.